EichorEICHOR
Condition: Respiratory Syncytial Virus Prevention Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Respiratory Syncytial Virus Prevention

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

RSV Vaccination in Immunocompromised Patients.
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06597916Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
Phase 3 · 1 location(s) · Centre Hospitalier Annecy Genevois · NCT07232706Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06881953
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.